We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
D.R. Horton
DHI
$42.1B
| $20K | ﹤0.01% |
579
-12,015
| -95% | -$401K |
|
727
Orthofix Medical
OFIX
$493M
| $20K | ﹤0.01% |
426
-361
| -46% | -$15K |
|
728
Photronics
PLAB
$1.92B
| $20K | ﹤0.01% |
2,075
-589
| -22% | -$6.22K |
|
729
Genpact
G
$6.07B
| $19K | ﹤0.01% |
+691
| New | +$17.9K |
|
|
WIN
730
DELISTED
Windstream Holdings Inc
WIN
| $19K | ﹤0.01% |
+976
| New | +$23.6K |
|
731
ANI Pharmaceuticals
ANIP
$1.8B
| $18K | ﹤0.01% |
377
+256
| +212% | +$12.3K |
|
732
SL Green Realty
SLG
$3.97B
| $18K | ﹤0.01% |
179
-3,714
| -95% | -$378K |
|
|
EGOV
733
DELISTED
NIC Inc
EGOV
| $18K | ﹤0.01% |
+969
| New | +$19.8K |
|
|
RATE
734
DELISTED
Bankrate Inc
RATE
| $17K | ﹤0.01% |
1,353
| – | – |
|
|
CA
735
DELISTED
CA, Inc.
CA
| $17K | ﹤0.01% |
497
-197
| -28% | -$6.37K |
|
736
Cooper-Standard Automotive
CPS
$546M
| $16K | ﹤0.01% |
163
-110
| -40% | -$11.8K |
|
737
OraSure Technologies
OSUR
$287M
| $16K | ﹤0.01% |
930
-1,374
| -60% | -$19.8K |
|
|
PRFT
738
DELISTED
Perficient Inc
PRFT
| $16K | ﹤0.01% |
852
+79
| +10% | +$1.37K |
|
|
FDC
739
DELISTED
First Data Corporation
FDC
| $16K | ﹤0.01% |
867
+152
| +21% | +$2.54K |
|
740
Myriad Genetics
MYGN
$303M
| $15K | ﹤0.01% |
592
+83
| +16% | +$1.76K |
|
741
Weis Markets
WMK
$1.94B
| $15K | ﹤0.01% |
305
+61
| +25% | +$3.36K |
|
|
LM
742
DELISTED
Legg Mason, Inc.
LM
| $15K | ﹤0.01% |
+380
| New | +$14.4K |
|
|
ATVI
743
DELISTED
Activision Blizzard
ATVI
| $15K | ﹤0.01% |
+252
| New | +$13.9K |
|
744
Daktronics
DAKT
$1.04B
| $14K | ﹤0.01% |
1,490
+576
| +63% | +$5.43K |
|
745
Eastman Chemical
EMN
$8.45B
| $14K | ﹤0.01% |
162
-3,451
| -96% | -$278K |
|
746
Hackett Group
HCKT
$284M
| $14K | ﹤0.01% |
880
| – | – |
|
747
NXP Semiconductors
NXPI
$59.9B
| $14K | ﹤0.01% |
132
+80
| +154% | +$8.57K |
|
|
ODP
748
DELISTED
ODP
ODP
| $14K | ﹤0.01% |
+251
| New | +$12.9K |
|
|
OME
749
DELISTED
Omega Protein
OME
| $14K | ﹤0.01% |
805
| – | – |
|
750
PennyMac Financial
PFSI
$4B
| $13K | ﹤0.01% |
798
+439
| +122% | +$7.26K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.